Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
Bihua, biopharma, BRAFm, Bristol, called, calling, Chairman, Chen, competitive, Cormorant, decision, deprioritization, deprioritized, differentiation, disagreement, EC, encouraging, fact, feedback, gated, glioma, greatly, groove, increasingly, independent, landscape, liaison, malignant, notified, ODD, Orphan, osimertinib, poster, quantity, regimen, region, resign, resignation, seeking, tenure, treat, unanimously, undertaken, user
Removed:
adenocarcinoma, agnostic, chemistry, comprise, conflict, disease, ductal, epidemic, expanded, franchise, governmental, health, healthcare, impacting, increasing, IND, indefinite, innovative, instability, mandated, nominated, pancreatic, pandemic, political, predicted, prevented, Russia, spread, tissue, trade, Ukraine, United
Filing tables
Filing exhibits
Related press release
ERAS similar filings
Filing view
External links